Snowball logo
logo
6009

Mayinglong Pharmaceutical Group Co Ltd

600993 • SHG
¥22.52+¥0.31  (1.4%)
Estimate
P/E
16.2
EPS
1.39
Beta
0.234
Growth
Revenue, YoY
4.46%
Net income, YoY
4.43%
FCF, YoY
108.02%
Forecast
P/E (FWD)
13.1
EPS (FWD)
1.715
About the company
Ticker
600993
ISIN
CNE000001HN2
Country
China
Sector (GICS)
Healthcare
Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

Frequently asked questions

What sector does Mayinglong Pharmaceutical Group Co Ltd (600993) operate in?

Mayinglong Pharmaceutical Group Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Mayinglong Pharmaceutical Group Co Ltd (600993) current stock price?

As of the latest data, Mayinglong Pharmaceutical Group Co Ltd stock price is CN¥22.52, with a previous close of CN¥22.21. Mayinglong Pharmaceutical Group Co Ltd gained CN¥0.31 in the last trading session, representing a 1.4% increase.

What is Mayinglong Pharmaceutical Group Co Ltd (600993) current market capitalization?

Mayinglong Pharmaceutical Group Co Ltd market cap is approximately 9.71 billion.

What is Mayinglong Pharmaceutical Group Co Ltd (600993) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.39, and the forward EPS is CN¥1.72.

What is Mayinglong Pharmaceutical Group Co Ltd (600993) Price-to-Earnings (P/E) ratio?

Mayinglong Pharmaceutical Group Co Ltd current P/E ratio is 16.2, with a forward P/E of 13.13.

Does Mayinglong Pharmaceutical Group Co Ltd (600993) pay dividends?

No. Mayinglong Pharmaceutical Group Co Ltd does not pay a dividend.

What is Mayinglong Pharmaceutical Group Co Ltd (600993) beta (volatility) score?

Mayinglong Pharmaceutical Group Co Ltd has a beta of 0.234, indicating lower volatility than the overall market.